Sun Pharma announces Drizalma Sprinkle (duloxetine delayed release capsules) is now covered by most Medicare Part D plans

Sun Pharma

9 March 2021 - Coverage for novel formulation of duloxetine now offered to 91% of lives in top 10 Medicare Part D plans.

Sun Pharmaceutical Industries today announced that the top 10 Medicare Part D plans, which include 91% of eligible U.S. lives, now cover Drizalma Sprinkle.

Read Sun Pharma press release

Michael Wonder

Posted by:

Michael Wonder